KR100880056B1 - 화상 치료용 제약 조성물 - Google Patents

화상 치료용 제약 조성물 Download PDF

Info

Publication number
KR100880056B1
KR100880056B1 KR1020037003022A KR20037003022A KR100880056B1 KR 100880056 B1 KR100880056 B1 KR 100880056B1 KR 1020037003022 A KR1020037003022 A KR 1020037003022A KR 20037003022 A KR20037003022 A KR 20037003022A KR 100880056 B1 KR100880056 B1 KR 100880056B1
Authority
KR
South Korea
Prior art keywords
diclofenac
pharmaceutical composition
emulsion
topical
gel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020037003022A
Other languages
English (en)
Korean (ko)
Other versions
KR20030027100A (ko
Inventor
도미니크 살린
쟝-뤽 키엔즐레
필리스 슈만
야체크 안체레빅츠
Original Assignee
노바티스 컨슈머 헬스에스에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노바티스 컨슈머 헬스에스에이 filed Critical 노바티스 컨슈머 헬스에스에이
Publication of KR20030027100A publication Critical patent/KR20030027100A/ko
Application granted granted Critical
Publication of KR100880056B1 publication Critical patent/KR100880056B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Polarising Elements (AREA)
  • Magnetic Heads (AREA)
  • Semiconductor Lasers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020037003022A 2000-09-01 2001-08-30 화상 치료용 제약 조성물 Expired - Fee Related KR100880056B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00118968.7 2000-09-01
EP00118968 2000-09-01
PCT/EP2001/010041 WO2002017905A2 (en) 2000-09-01 2001-08-30 Treatment of burns

Publications (2)

Publication Number Publication Date
KR20030027100A KR20030027100A (ko) 2003-04-03
KR100880056B1 true KR100880056B1 (ko) 2009-01-22

Family

ID=8169725

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037003022A Expired - Fee Related KR100880056B1 (ko) 2000-09-01 2001-08-30 화상 치료용 제약 조성물

Country Status (31)

Country Link
US (1) US20030187069A1 (enExample)
JP (1) JP2004507497A (enExample)
KR (1) KR100880056B1 (enExample)
CN (1) CN100350905C (enExample)
AR (1) AR030522A1 (enExample)
AT (1) AT504040B1 (enExample)
AU (2) AU8770601A (enExample)
BE (1) BE1014352A5 (enExample)
CA (1) CA2414921C (enExample)
CH (1) CH695416A5 (enExample)
CZ (1) CZ303849B6 (enExample)
DE (2) DE10196483T1 (enExample)
DK (1) DK200300274A (enExample)
ES (1) ES2201941B1 (enExample)
FI (1) FI119840B (enExample)
FR (1) FR2813530B1 (enExample)
GB (1) GB2381455B (enExample)
GR (1) GR1004434B (enExample)
HU (1) HU230783B1 (enExample)
IL (2) IL153816A0 (enExample)
IT (1) ITMI20011820A1 (enExample)
LU (1) LU91009B1 (enExample)
MX (1) MXPA03001830A (enExample)
NL (1) NL1018862C2 (enExample)
NO (1) NO330590B1 (enExample)
PL (1) PL359807A1 (enExample)
RU (1) RU2314802C2 (enExample)
SE (1) SE527137C2 (enExample)
TW (1) TWI290464B (enExample)
WO (1) WO2002017905A2 (enExample)
ZA (1) ZA200300284B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR041021A1 (es) * 2002-08-22 2005-04-27 Novartis Consumer Health Sa Composicion topica
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
CN105395544A (zh) * 2014-08-23 2016-03-16 南京海纳医药科技有限公司 双氯芬酸依泊胺凝胶制备方法及药物用途
WO2016038553A1 (en) 2014-09-10 2016-03-17 Novartis Consumer Health S.A. Topical diclofenac sodium compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092393A2 (en) * 1982-04-16 1983-10-26 Unilever Plc Powder tight carton
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
JP2000500449A (ja) * 1995-11-13 2000-01-18 ピットミー・インターナショナル・ナムローゼ・フェンノートシャップ 一酸化二窒素を含む鎮痛剤、抗炎症剤、および抗発熱剤のための投与媒体とそれらの医薬組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
CH655656B (enExample) * 1982-10-07 1986-05-15
JPS59170011A (ja) * 1983-03-16 1984-09-26 Pola Chem Ind Inc 日焼け防止化粧料
DE3707532C2 (de) 1987-03-09 1998-05-28 Bauer Johann Verwendung einer Kombination von Extr. Gingko biloba oder mindestens einem Gingkolid und Acetylsalicylsäure oder DL-Lysin-mono-acetylsalicylat oder Diflunisal zur Behandlung von Verbrennungen, Verbrühungen, Strahlenschäden und Erfrierungen
US4847071A (en) 1987-10-22 1989-07-11 The Procter & Gamble Company Photoprotection compositions comprising tocopherol sorbate and an anti-inflammatory agent
IT1229489B (it) 1988-12-09 1991-09-03 Altergon Sa Composizioni farmaceutiche lipidiche per uso topico atte a veicolare un principio attivo antiinfiammatorio idrosolubile
RU2008002C1 (ru) * 1989-03-23 1994-02-28 Центр по химии лекарственных средств Противовоспалительный состав и способ его получения
JP3526887B2 (ja) 1993-04-23 2004-05-17 帝國製薬株式会社 消炎鎮痛外用貼付剤
JP4181232B2 (ja) * 1997-07-18 2008-11-12 帝國製薬株式会社 ジクロフェナクナトリウム含有油性外用貼付製剤
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
EP0923937B1 (en) * 1997-12-08 2004-03-10 Council of Scientific and Industrial Research A herbal formulation useful as a therapeutic and cosmetic application for the treatment of general skin disorders
DE19844116A1 (de) 1998-08-06 2000-02-24 Vascular Biotech Gmbh Wirkstoffkombination insbesondere zur Prophylaxe und Therapie von ischämischen Organschäden und Reperfusionssyndromen
RU2140258C1 (ru) * 1999-03-17 1999-10-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Гидрофильная фармацевтическая композиция, обладающая противовоспалительным действием
WO2000072883A2 (en) * 1999-06-02 2000-12-07 Aviana Biopharm Pharmaceutical transdermal compositions
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
DE10025328A1 (de) * 2000-05-23 2001-12-06 Lohmann Therapie Syst Lts Acetylsalicylsäure enthaltendes superfizielles therapeutisches System zur Behandlung von Hautschmerzen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0092393A2 (en) * 1982-04-16 1983-10-26 Unilever Plc Powder tight carton
US5674912A (en) * 1991-03-01 1997-10-07 Warner-Lambert Company Sunscreen-wound healing compositions and methods for preparing and using same
JP2000500449A (ja) * 1995-11-13 2000-01-18 ピットミー・インターナショナル・ナムローゼ・フェンノートシャップ 一酸化二窒素を含む鎮痛剤、抗炎症剤、および抗発熱剤のための投与媒体とそれらの医薬組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CUTIS 제66권 53~58쪽*

Also Published As

Publication number Publication date
GB0304150D0 (en) 2003-03-26
US20030187069A1 (en) 2003-10-02
BE1014352A5 (fr) 2003-09-02
HUP0300876A3 (en) 2009-08-28
ES2201941A1 (es) 2004-03-16
IE20010782A1 (en) 2003-04-16
ZA200300284B (en) 2004-03-10
RU2314802C2 (ru) 2008-01-20
ITMI20011820A0 (it) 2001-08-28
LU91009B1 (de) 2003-02-19
FR2813530A1 (fr) 2002-03-08
CN100350905C (zh) 2007-11-28
CN1449282A (zh) 2003-10-15
NO20030767D0 (no) 2003-02-18
CA2414921A1 (en) 2002-03-07
GB2381455B (en) 2004-06-30
AR030522A1 (es) 2003-08-20
PL359807A1 (en) 2004-09-06
NO330590B1 (no) 2011-05-23
AT504040A1 (de) 2008-02-15
FR2813530B1 (fr) 2005-05-20
IL153816A0 (en) 2003-07-31
AU8770601A (en) 2002-03-13
JP2004507497A (ja) 2004-03-11
DK200300274A (da) 2003-02-24
CA2414921C (en) 2010-02-09
TWI290464B (en) 2007-12-01
ITMI20011820A1 (it) 2003-02-28
HU230783B1 (hu) 2018-05-02
ES2201941B1 (es) 2005-06-01
GB2381455A (en) 2003-05-07
GR1004434B (el) 2004-02-03
NO20030767L (no) 2003-02-18
HK1056828A1 (en) 2004-03-05
CZ2003574A3 (cs) 2003-06-18
SE0300535D0 (sv) 2003-02-28
HUP0300876A2 (hu) 2003-10-28
SE0300535L (sv) 2003-04-29
AU2001287706B2 (en) 2005-04-07
FI119840B (fi) 2009-04-15
WO2002017905A3 (en) 2002-05-16
IL153816A (en) 2011-07-31
DE10196483B4 (de) 2023-08-24
FI20030276A7 (fi) 2003-02-25
NL1018862C2 (nl) 2002-03-05
AT504040B1 (de) 2008-07-15
CH695416A5 (de) 2006-05-15
SE527137C2 (sv) 2005-12-27
GR20010100390A (el) 2002-07-31
KR20030027100A (ko) 2003-04-03
CZ303849B6 (cs) 2013-05-29
MXPA03001830A (es) 2004-11-01
WO2002017905A2 (en) 2002-03-07
DE10196483T1 (de) 2003-07-31

Similar Documents

Publication Publication Date Title
US20110033545A1 (en) Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
KR100880056B1 (ko) 화상 치료용 제약 조성물
AU2001287706A1 (en) Treatment of burns
WO2024013283A1 (fr) Nouveau regime posologique d'une composition comprenant de la brimonidine pour son utilisation dans la prevention et le traitement des dommages cutanes resultant d'un rayonnement
NZ606177A (en) Compositions for the treatment of actinic keratosis
IE83245B1 (en) Treatment of burns
CA2800716C (en) Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
JP2024514843A (ja) 発作性疾患を治療するための医薬組成物及び方法
RU2336078C2 (ru) Применение веществ синтеза порфиринов для применения в фототерапии, а также для лечения заболеваний кожи и/или суставов
UA82472C2 (uk) Трансдермальна фармацевтична композиція, що містить ацетилсаліцилову кислоту, для лікування кальцифікації
Wible Jr et al. Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs
RU2118155C1 (ru) Мазь для лечения заболеваний и повреждений кожи "галлодерм"

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20121226

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20131220

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

FPAY Annual fee payment

Payment date: 20141231

Year of fee payment: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

FPAY Annual fee payment

Payment date: 20151230

Year of fee payment: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

FPAY Annual fee payment

Payment date: 20161229

Year of fee payment: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20171228

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20190116

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20190116

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301